ScreenerHero

EAPI Euroapi S.A.

EPA · FR · Healthcare · Drug Manufacturers - Specialty & Generic · euroapi.com
0.7310EUR-1.08%Mkt Cap: 75.90M $P/E: —

Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.30BUSDP/E 25.0
TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
$57.06BUSD
TEVA
Teva Pharmaceutical Industries Limited Ordinary Shares
$46.10BUSDP/E 65.9
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$38.70BUSDP/E 18.3
ZOE
Zoetis Inc.
$28.27BUSDP/E 12.1
ZTS
Zoetis Inc. Class A Common Stock
$28.80BUSDP/E 11.4
UTHR
United Therapeutics Corporation - Common Stock
$23.23BUSDP/E 19.4
VTRS
Viatris Inc. - Common Stock
$20.22BUSD
SOBI
Swedish Orphan Biovitrum AB
$14.24BUSDP/E 109.4
NBIX
Neurocrine Biosciences, Inc. - Common Stock
$14.55BUSDP/E 21.0
IPN
Ipsen S.A.
$12.60BUSDP/E 22.8
ELAN
Elanco Animal Health Incorporated Common Stock
$11.06BUSD
RDY
Dr. Reddy's Laboratories Ltd Common Stock
$10.20BUSDP/E 29.2
KRK
Krka, d. d.
$8.50BUSDP/E 18.4
AMRX
Amneal Pharmaceuticals, Inc. - Class A Common Stock
$7.07BUSDP/E 42.3
ALKS
Alkermes plc - Ordinary Shares
$7.00BUSDP/E 109.9
HIMS
Hims & Hers Health, Inc. Class A Common Stock
$6.77BUSD
LNTH
Lantheus Holdings, Inc. - Common Stock
$6.53BUSDP/E 23.9
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
$5.83BUSDP/E 76.6
INDV
Indivior Pharmaceuticals, Inc. - Common Stock
$4.21BUSDP/E 12.8

Key Statistics

Company
Market Cap75.90M USD
Enterprise Value138.69M USD
Revenue (TTM)863.70M USD
Gross Profit157.39M USD
Net Income (TTM)-229.57M USD
Revenue/Share8.39 EUR
Last Price0.7310 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees3.0K
CountryFR
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINFR0014008VX5
Valuation
P/E (Trailing)—
P/E (Forward)-3.46
PEG—
EV/EBITDA0.97
EV/Revenue0.16
P/S0.09
P/B0.15
EPS (TTM)-3.42
EPS (Forward)-0.21
52W Range
0.71301% of range3.400
52W High3.400 EUR
52W Low0.7130 EUR
Profitability
Gross Margin16.98%
Oper. Margin-2.86%
EBITDA Margin16.63%
Profit Margin-24.77%
ROE-26.80%
ROA-16.19%
Growth
Revenue Growth-14.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF139.67M USD
CapEx (TTM)85.33M USD
FCF Margin19.21%
FCF Yield218.58%
Net Debt61.96M USD
Net Debt/EBITDA0.43
Balance Sheet
Debt/Equity0.08
Current Ratio2.01
Quick Ratio0.53
Book Value/Sh4.90 EUR
Cash/Share0.54 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 EUR
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating4.5 (Sell)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)1.000 EUR
Upside (mean)+36.8%
Target Range0.7000 EUR – 1.400 EUR
0.7000+36.8% to mean1.400
# Analysts4
Ownership
Shares Out.95.53M
Float50.80M
Insiders34.84%
Institutions35.90%
Technical
SMA 500.9109 (-19.7%)
SMA 2001.422 (-48.6%)
Beta0.96
S&P 52W Chg14.58%
Avg Vol (30d)215.50K
Avg Vol (10d)230.04K
Technical Indicators
RSI (14)25.6
MACD-0.0554
MACD Signal-0.0562
MACD Hist.+0.0008
BB Upper0.8887 EUR
BB Middle0.7952 EUR
BB Lower0.7017 EUR
BB Width23.52%
ATR (14)0.0338 EUR
Vol Ratio (20d)1.16x